CordenPharma's resilience: 'The CDMO industry is not going away'

While the biotech industry has faced funding difficulties after peaking during the Covid-19 years, CDMO CordenPharma is managing to weather the storm.

Related Keywords

Colorado ,United States ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Switzerland ,Brittany Hayes ,Sylke Hassel ,Eli Lilly ,Reuters ,Biopharma Reporter ,Jefferies Healthcare ,Bio Developments ,Dmo ,Contract Manufacturing ,Covid 19 ,Obesity ,Manufacturing ,